127 related articles for article (PubMed ID: 20935334)
1. Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.
Jokoji R; Yamasaki T; Minami S; Komuta K; Sakamaki Y; Takeuchi K; Tsujimoto M
J Clin Pathol; 2010 Dec; 63(12):1066-70. PubMed ID: 20935334
[TBL] [Abstract][Full Text] [Related]
2. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
4. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
[TBL] [Abstract][Full Text] [Related]
5. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
Sanders HR; Li HR; Bruey JM; Scheerle JA; Meloni-Ehrig AM; Kelly JC; Novick C; Albitar M
Cancer Genet; 2011 Jan; 204(1):45-52. PubMed ID: 21356191
[TBL] [Abstract][Full Text] [Related]
6. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
[TBL] [Abstract][Full Text] [Related]
7. Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas.
Yoshida A; Tsuta K; Nitta H; Hatanaka Y; Asamura H; Sekine I; Grogan TM; Fukayama M; Shibata T; Furuta K; Kohno T; Tsuda H
J Thorac Oncol; 2011 Oct; 6(10):1677-86. PubMed ID: 21921848
[TBL] [Abstract][Full Text] [Related]
8. Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
Yamamoto M; Takeuchi K; Shimoji M; Maniwa T; Isaka M; Nakagawa K; Ohde Y; Kondo H; Nakajima T
Cancer Sci; 2012 Feb; 103(2):390-2. PubMed ID: 22296236
[TBL] [Abstract][Full Text] [Related]
9. Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
Liu L; Zhan P; Zhou X; Song Y; Zhou X; Yu L; Wang J
PLoS One; 2015; 10(3):e0117032. PubMed ID: 25785456
[TBL] [Abstract][Full Text] [Related]
10. Detection of ALK fusion in lung cancer using fluorescence in situ hybridization.
Kobayashi M; Sonobe M; Takahashi T; Yoshizawa A; Kikuchi R; Date H
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):426-31. PubMed ID: 22879549
[TBL] [Abstract][Full Text] [Related]
11. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer.
Mano H
Cancer Sci; 2008 Dec; 99(12):2349-55. PubMed ID: 19032370
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Pekar-Zlotin M; Hirsch FR; Soussan-Gutman L; Ilouze M; Dvir A; Boyle T; Wynes M; Miller VA; Lipson D; Palmer GA; Ali SM; Dekel S; Brenner R; Bunn PA; Peled N
Oncologist; 2015 Mar; 20(3):316-22. PubMed ID: 25721120
[TBL] [Abstract][Full Text] [Related]
13. [Detection of ALK positive pulmonary adenocarcinoma using immunostaining].
Ikeda S; Takabe K; Inagaki M; Funakoshi N; Suzuki K
Rinsho Byori; 2010 Jun; 58(6):565-70. PubMed ID: 20662267
[TBL] [Abstract][Full Text] [Related]
14. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
Yoshida A; Tsuta K; Watanabe S; Sekine I; Fukayama M; Tsuda H; Furuta K; Shibata T
Lung Cancer; 2011 Jun; 72(3):309-15. PubMed ID: 21036415
[TBL] [Abstract][Full Text] [Related]
15. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Takeuchi K; Choi YL; Soda M; Inamura K; Togashi Y; Hatano S; Enomoto M; Takada S; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
Clin Cancer Res; 2008 Oct; 14(20):6618-24. PubMed ID: 18927303
[TBL] [Abstract][Full Text] [Related]
16. A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK.
Penzel R; Schirmacher P; Warth A
J Thorac Oncol; 2012 Jul; 7(7):1198-9. PubMed ID: 22706607
[TBL] [Abstract][Full Text] [Related]
17. A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.
Soda M; Isobe K; Inoue A; Maemondo M; Oizumi S; Fujita Y; Gemma A; Yamashita Y; Ueno T; Takeuchi K; Choi YL; Miyazawa H; Tanaka T; Hagiwara K; Mano H; ;
Clin Cancer Res; 2012 Oct; 18(20):5682-9. PubMed ID: 22908099
[TBL] [Abstract][Full Text] [Related]
18. Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report.
Owada Y; Yonechi A; Higuchi M; Suzuki H
World J Surg Oncol; 2016 Mar; 14():81. PubMed ID: 26964537
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical screening and fluorescence in situ hybridization confirmation of ALK translocation in lung adenocarcinoma and its clinicopathological significance: a single-center large-scale investigation of Chinese patients.
Wang WY; Liang DN; Yao WQ; Wu WL; Li JN; Chen M; Liao DY; Zhang M; Li GD
Hum Pathol; 2014 Jul; 45(7):1414-22. PubMed ID: 24775606
[TBL] [Abstract][Full Text] [Related]
20. Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
Kijima T; Takeuchi K; Tetsumoto S; Shimada K; Takahashi R; Hirata H; Nagatomo I; Hoshino S; Takeda Y; Kida H; Goya S; Tachibana I; Kawase I
Cancer Sci; 2011 Aug; 102(8):1602-4. PubMed ID: 21767331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]